<DOC>
	<DOCNO>NCT00420485</DOCNO>
	<brief_summary>This study evaluate Maximum Tolerated Dose dose limit toxicity gimatecan administer orally patient advance solid tumor</brief_summary>
	<brief_title>Dose-escalation Study Gimatecan Administered Two Different Schedules Adult Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Camptothecin</mesh_term>
	<criteria>Inclusion criterion : Advanced metastatic cancer 18 year Exclusion criterion : Previous treatment 4 cycle carboplatin ; Previous treatment 2 course nitrosourea mitomycin ; Previous radiation therapy great equal 25 % hematopoietic reserve ; Severe and/or uncontrolled medical condition Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Maximum Tolerated Dose</keyword>
	<keyword>Solid Tumors</keyword>
	<keyword>Dose Limiting Toxicity</keyword>
	<keyword>Topoisomerase-1 Inhibitor</keyword>
</DOC>